Andres Maldonado
Stock Analyst at HC Wainwright & Co.
(1.91)
# 2,947
Out of 4,832 analysts
93
Total ratings
27.17%
Success rate
-6.49%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andres Maldonado
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IBRX ImmunityBio | Reiterates: Buy | $8 | $2.49 | +221.29% | 3 | May 12, 2025 | |
| CRBP Corbus Pharmaceuticals Holdings | Maintains: Buy | $50 → $40 | $6.97 | +473.89% | 2 | May 7, 2025 | |
| TCRX TScan Therapeutics | Maintains: Buy | $15 → $10 | $1.32 | +657.58% | 1 | May 7, 2025 | |
| ERAS Erasca | Reiterates: Buy | $6 | $1.26 | +376.19% | 10 | Apr 30, 2025 | |
| FHTX Foghorn Therapeutics | Reiterates: Buy | $13 | $4.13 | +214.77% | 1 | Apr 30, 2025 | |
| STRO Sutro Biopharma | Reiterates: Neutral | $2 | $0.73 | +172.46% | 1 | Apr 29, 2025 | |
| TARA Protara Therapeutics | Reiterates: Buy | $23 | $3.13 | +636.00% | 1 | Apr 28, 2025 | |
| CGON CG Oncology | Reiterates: Buy | $75 | $24.19 | +210.05% | 13 | Apr 28, 2025 | |
| DAWN Day One Biopharmaceuticals | Reiterates: Buy | $36 | $6.19 | +481.58% | 14 | Apr 3, 2025 | |
| MURA Mural Oncology | Maintains: Buy | $18 → $6 | $2.58 | +132.56% | 5 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $0.98 | +1,429.52% | 16 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $3.00 | +733.33% | 2 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $50 | $30.54 | +63.72% | 13 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.07 | +273.83% | 11 | Nov 11, 2024 |
ImmunityBio
May 12, 2025
Reiterates: Buy
Price Target: $8
Current: $2.49
Upside: +221.29%
Corbus Pharmaceuticals Holdings
May 7, 2025
Maintains: Buy
Price Target: $50 → $40
Current: $6.97
Upside: +473.89%
TScan Therapeutics
May 7, 2025
Maintains: Buy
Price Target: $15 → $10
Current: $1.32
Upside: +657.58%
Erasca
Apr 30, 2025
Reiterates: Buy
Price Target: $6
Current: $1.26
Upside: +376.19%
Foghorn Therapeutics
Apr 30, 2025
Reiterates: Buy
Price Target: $13
Current: $4.13
Upside: +214.77%
Sutro Biopharma
Apr 29, 2025
Reiterates: Neutral
Price Target: $2
Current: $0.73
Upside: +172.46%
Protara Therapeutics
Apr 28, 2025
Reiterates: Buy
Price Target: $23
Current: $3.13
Upside: +636.00%
CG Oncology
Apr 28, 2025
Reiterates: Buy
Price Target: $75
Current: $24.19
Upside: +210.05%
Day One Biopharmaceuticals
Apr 3, 2025
Reiterates: Buy
Price Target: $36
Current: $6.19
Upside: +481.58%
Mural Oncology
Mar 26, 2025
Maintains: Buy
Price Target: $18 → $6
Current: $2.58
Upside: +132.56%
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $0.98
Upside: +1,429.52%
Mar 11, 2025
Reiterates: Buy
Price Target: $25
Current: $3.00
Upside: +733.33%
Nov 26, 2024
Maintains: Buy
Price Target: $40 → $50
Current: $30.54
Upside: +63.72%
Nov 11, 2024
Reiterates: Buy
Price Target: $4
Current: $1.07
Upside: +273.83%